Abstract: The present invention relates to optimized gas supply utilizing photoplethysmography. Flow rate, pressure or amount of gas adjusted as a function of blood oxygen saturation data, photoplethysmography signals, or both, obtained from the pulse oximeter probe.
Type:
Grant
Filed:
September 26, 2006
Date of Patent:
June 17, 2014
Assignee:
University of Florida Research Foundation, Inc.
Abstract: Disclosed is a modified photoautotrophic bacterium comprising genes of interest that are modified in terms of their expression and/or coding region sequence, wherein modification of the genes of interest increases production of a desired product in the bacterium relative to the amount of the desired product production in a photoautotrophic bacterium that is not modified with respect to the genes of interest.
Type:
Grant
Filed:
October 19, 2007
Date of Patent:
June 17, 2014
Assignee:
Arizona Board of Regents on behalf of Arizona State University
Abstract: A method of enriching stem or progenitor cells that includes growing a heterogeneous cell sample comprising stem and/or progenitor cells on a first substrate that is hydrophobic and has an elastic modulus less than about 100 MPa; recovering the heterogeneous cell sample from the first substrate; growing the recovered heterogeneous cell sample on a second substrate that is hydrophilic and has an elastic modulus higher than the elastic modulus of the first substrate to produce a subpopulation of nonadherent cells and a subpopulation of adherent cells; and recovering the nonadherent cell subpopulation, which is enriched for stem and/or progenitor cells.
Abstract: An organ protectant solution which is intravenously administerable includes a high concentration of cell impermeant molecules which have a charge and/or molecular weight which permit passage across a capillary endothelium and into an interstitial space in said subject but which are too large and/or charged to cross a cell plasma membrane such that said one or more cell impermeant molecules preferentially load into an extracellular fluid compartment can be used to to allow for improved organ harvesting from DCD and brain death donors for transplantation purposes and also can be used extend the “Golden Hour” for traumatic and hemorrhagic shock patients thereby allowing more time for those patients to reach a point of care facility to receive medical treatment.
Abstract: A vehicle comprises a trailer angle detection apparatus and a trailer backup control system. The trailer angle detection apparatus is configured for outputting hitch angle information generated as a function of an angle between the vehicle and a trailer towably attached thereto. The trailer backup control system includes a jackknife enabling condition detector and a jackknife counter-measures controller coupled to the trailer angle detection apparatus. The jackknife enabling condition detector is coupled to the trailer angle detection apparatus for receiving the hitch angle information therefrom and for determining if a jackknife enabling condition has been attained at a particular point in time during backing of the trailer by the vehicle. The jackknife counter-measures controller implements a vehicle speed reducing action in response to the jackknife enabling condition detector determining that the jackknife enabling condition has been attained at the particular point in time during backing of the trailer.
Type:
Grant
Filed:
April 10, 2012
Date of Patent:
June 17, 2014
Assignees:
Ford Global Technologies, The Regents of the University of Michigan
Inventors:
Matt Y. Rupp, David Dean Smit, Roger Arnold Trombley, Thomas Edward Pilutti, Erick Michael Lavoie, Taehyun Shim
Abstract: A catalyst for the generation of hydrogen from a small organic molecule comprises a tertiary metal composition where: the first metal is either Pt or Ru; the second metal is at least one of Pt, Ru, Au, Pd, Rh, Ir, Os, and/or Re; and Bi, primarily present in the form of an oxide or of a mixture of oxides and carbonates and in the +3 oxidation state. A portion of the first and/or second metal may be in the form of an oxide. The catalyst can be in the form of a nanoparticle and supported on an inert substrate, such as carbon. The catalyst can be used for dehydrogenation of formic acid or other small organic molecules in a liquid state at ambient pressures and at temperatures below the boiling point of the liquid. The liquid can be an aqueous solution of the small organic molecule.
Type:
Grant
Filed:
August 25, 2010
Date of Patent:
June 17, 2014
Assignee:
The University of Hong Kong
Inventors:
Kwong Yu Chan, Shaoan Cheng, Kwok Ying Tsang, Siu Wa Ting, Nicole Kathleen Van Der Laak
Abstract: An apparatus and method for human activity and facial expression modeling and recognition are based on feature extraction techniques from time sequential images. The human activity modeling includes determining principal components of depth and/or binary shape images of human activities extracted from video clips. Independent Component Analysis (ICA) representations are determined based on the principal components. Features are determined through Linear Discriminant Analysis (LDA) based on the ICA representations. A codebook is determined using vector quantization. Observation symbol sequences in the video clips are determined. And human activities are learned using the Hidden Markov Model (HMM) based on status transition and an observation matrix.
Type:
Grant
Filed:
June 4, 2010
Date of Patent:
June 17, 2014
Assignees:
Samsung Electronics Co., Ltd., Kyung Hee University, University-Industry Cooperation Group of Kyung Hee University
Inventors:
Hyun-Soo Kim, Jong-Chang Lee, Dae-Hyun Sim, Tae-Seong Kim
Abstract: Apparatus for use in a magnetic resonance imaging system, the imaging system generating a magnetic imaging field in an imaging region (5), the apparatus including at least one coil for at least one of transmitting, receiving or transceiving an electromagnetic field, a field component (4) (such as a coil or a shield) and a drive (6) coupled to the field component for moving the field component (4) relative to the imaging region (5) to thereby modify the electromagnetic field during imaging process. The same concept can also be applied to nuclear imaging or nuclear spectroscopy apparatus.
Type:
Grant
Filed:
June 19, 2009
Date of Patent:
June 17, 2014
Assignee:
The University of Queensland
Inventors:
Adnan Trakic, Ewald Weber, Bing Keong Li, Stephen James Wilson, Wang Hua, Feng Liu, Stuart Crozier
Abstract: Disclosed herein is an electric generating system using a solar cell, including: a DC/DC converter that converts output voltage generated from a solar cell into DC voltage and has a converter switching device; a snubber device that has a snubber switch clamping voltage applied to the converter switching device; and a control device that detects the voltage applied to the converter switching device and controls an operation of the snubber switch according to a detected voltage level applied to the converter switching device, thereby increasing the efficiency of the electric generating system using a solar cell while reducing switching loss and conduction loss.
Type:
Grant
Filed:
February 2, 2012
Date of Patent:
June 17, 2014
Assignees:
Samsung Electro-Mechanics Co., Ltd., Sungkyunkwan University Foundation for Corporate Collaboration
Inventors:
Tae Won Lee, Young Ho Kim, Yong Hyok Ji, Doo Young Song, Min Ho Heo, Tae Hoon Kim, Chung Yuen Won
Abstract: The present invention provides a valving arrangement device for an aerosol spray device comprising a pressurized or pressurizable container which, when in its fully open configuration, has a loss coefficient of 10 or less. There is also provided a valving arrangement device for an aerosol spray device wherein, when in its fully open configuration, said valving arrangement is such that fluid passes from the upstream fluid flow path section into the downstream fluid flow path section with any change of the cross-sectional area of the fluid being less than 50% and with any change in direction of the flow being less than 40°.
Type:
Grant
Filed:
November 16, 2010
Date of Patent:
June 17, 2014
Assignee:
The University of Salford
Inventors:
Ghasem Ghavami-Nasr, Andrew John Yule, Martin Laurence Burby
Abstract: An apparatus and method are provided for producing fuel briquettes from high moisture fine coal. The apparatus includes a coal fine pelletizer, a pellet dryer and a fuel briquette former all provided in-line for the efficient production of fuel briquettes. The method comprises forming pellets from coal fines, drying those pellets to a desired moisture content of about 1 to about 10% and forming fuel briquettes from the dried pellets.
Type:
Grant
Filed:
August 28, 2012
Date of Patent:
June 17, 2014
Assignee:
University of Kentucky Research Foundation
Abstract: The present disclosure relates to a gas sensor including a nanopore electrode and a fluorine compound coated on the nanopore electrode, and also relates to a preparing method of the gas sensor.
Type:
Grant
Filed:
August 16, 2012
Date of Patent:
June 17, 2014
Assignee:
Ewha University—Industry Collaboration Foundation
Inventors:
Youngmi Lee, Myung Hwa Kim, Min-Cheol Oh, Hyunkyung Do, Kyung Jang, Ji-Hyang Jang
Abstract: This invention relates to agents capable of reducing the activity, amount or density of complement regulatory proteins (CRPs) on target cells. The invention also provides methods of identification of such agents, methods of making, and uses thereof.
Type:
Grant
Filed:
March 31, 2010
Date of Patent:
June 17, 2014
Assignees:
University of Washington through its Center for Commercialization, Compliment Corporation
Inventors:
André Lieber, Hongjie Wang, Ronald Jay Berenson, Darrick Carter
Abstract: A method of double crossover homologous recombination in a host cell comprising: a first homologous recombination event between a donor DNA molecule comprising a first element of a selectable allele and an acceptor DNA molecule comprising a second element of the selectable allele in the host cell, thereby to form a product of the first homologous recombination event in the host cell; and a second homologous recombination event within the product of the first homologous recombination event, thereby to form a product of the second homologous recombination event in the host cell which confers a selectable phenotype on the host cell, wherein the selectable phenotype arises following and in dependency on the formation of a selectable allele from the first and second elements of the selectable allele.
Abstract: The present invention relates to compositions and methods for neuroprotection. In particular, provided herein are compositions (e.g., hepatocyte secretory factors) for alleviating and/or protecting against neuronal damage (e.g., resulting from stroke), and methods of use thereof.
Abstract: Slowness dispersion characteristics of multiple possibly interfering signals in broadband acoustic waves as received by an array of two or more sensors are extracted without using a physical model. The problem of dispersion extraction is mapped to the problem of reconstructing signals having a sparse representation in an appropriately chosen over-complete dictionary of basis elements. A sparsity penalized signal reconstruction algorithm is described where the sparsity constraints are implemented by imposing a l1 norm type penalty. The candidate modes that are extracted are consolidated by means of a clustering algorithm to extract phase and group slowness estimates at a number of frequencies which are then used to reconstruct the desired dispersion curves. These estimates can be further refined by building time domain propagators when signals are known to be time compact, such as by using the continuous wavelet transform.
Type:
Grant
Filed:
December 20, 2012
Date of Patent:
June 17, 2014
Assignees:
Schlumberger Technology Corporation, Trustees of Boston University
Abstract: The invention enables high-throughput screening of compounds in living systems to detect unanticipated or unintended biological actions. The invention also allows for screening, detection, and confirmation of new indications for approved drugs. Screening and detection of toxic effects of compounds also can be achieved by using the methods of the invention. The methods comprise administering isotope-labeled substrates to a living system so that the label is incorporated into molecules in a manner that reveals flux rates through metabolic pathways thought to be involved in a disease. Comparisons between living systems exposed to compounds and living systems not so exposed reveals the effects of the compounds on the flux rates through the metabolic pathways. Combinations or mixtures of compounds can be systematically screened to detect unantidpated or unintended biological actions, including synergistic actions, in the same manner.
Type:
Application
Filed:
January 29, 2014
Publication date:
June 12, 2014
Applicant:
The Regents of the University of California
Abstract: An apparatus and a method for providing a tactile sensation for a virtual image are disclosed. The disclosed apparatus includes: a display unit for displaying an image including a virtual image; an image acquisition unit for acquiring an image of a user body; a determiner unit for determining whether or not a user attempts an interaction with the virtual image by using an image acquired by the image acquisition unit; a content analyzer unit for acquiring a time at which a virtual image is shown and position information of the shown virtual image from a displayed content; a tactile-sensation provider unit for providing a tactile sensation to a preset body part of the user based on a determination result of the determiner unit; and a tactile-sensation provision controller for adjusting an ejector nozzle of the tactile-sensation provider unit based on a virtual image showing time and position acquired by the content analyzer unit.
Type:
Application
Filed:
December 14, 2012
Publication date:
June 12, 2014
Applicant:
Industry-University Cooperation Foundation Hanyang University
Inventors:
Jong-II Park, Byung-Kuk Seo, Dae-Sun Lee, Jung-Sik Park
Abstract: This disclosure relates to prodrugs of uridine diphosphate (UDP) derivatives, compositions comprising therapeutically effective amounts of those prodrugs of the UDP derivatives and methods of using those prodrugs or compositions in treating disorders that are responsive to ligands, such as agonists, of P2Y6 receptor, e.g., neuronal disorders, including neurodegenerative disorders (e.g., Alzheimer's disease, Parkinson's disease) and traumatic CNS injury, pain, Down Syndrome (DS), glaucoma, and inflammatory conditions.